Position in ACAD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,856,403
-$1,377,357 QoQ
Shares Held
263,091
-2.9% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 57.10191530687101.ToString("F0")%
Shared 0.ToString("F0")%
None 42.89808469312899.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. ACAD ranks #94 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in ACAD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,856,403 | 263,091 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,233,760 | 270,826 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $6,955,151 | 325,921 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $6,728,479 | 311,937 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $5,393,680 | 324,725 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $13,090,155 | 713,360 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,784,485 | 441,124 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $10,209,045 | 628,249 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $8,782,821 | 475,004 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $20,692,776 | 660,900 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $9,542,947 | 457,915 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,729,756 | 280,992 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $29,825,633 | 1,584,784 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $33,360,213 | 2,095,491 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $30,412,601 | 1,858,961 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $26,865,682 | 1,906,720 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $55,956,796 | 2,310,355 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $51,398,785 | 2,202,176 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $38,462,376 | 2,315,616 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $58,086,441 | 2,381,568 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $36,164,192 | 1,401,713 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $50,349,159 | 941,810 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $35,880,980 | 869,842 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $52,180,616 | 1,076,555 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $46,361,177 | 1,097,306 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||